FlowBank
en

Market Insights

Market Insights / Covid-19 / Articles
Macro ・ Covid-19
18 October 2021

Supply chain bottlenecks: is the end in sight?

The good news is that the global economy is recovering. The bad news is that supply is not matching this demand. First, companies were not prepared for the speed and scale of the recovery. Second, with ongoing Covid risks disrupting production, ...

Covid-19
25 August 2021

How did Moderna reach the moon? Mars next?

Moderna stock has rallied from around $104 per share at the ...

Covid-19
11 May 2021

Is the impact of the covid resurgence on Indian markets overhyped?

Indian markets are facing headwinds from a pandemic resurgence that has spooked foreign investors, and inflation threats loom. But falling Indian share prices could provide opportunities for those looking through the ...

Covid-19
18 March 2021

Covid is a chance for pharma to gain our confidence back

Big pharma has been unloved in the last decade, both for safety and money reasons. However, these are heady times for the industry, both from the financial gains to be made from the covid vaccine and the marketing and PR value of having developed ...

Commodities ・ Covid-19
15 March 2021

Factories will struggle to keep up with rising demand

As vaccines are rolling out and social distancing measures are loosening up, the economy is getting back on track. However, we have rarely seen such a quick recovery, and many companies struggle to adapt to the new cruising speed.

Forex ・ Macro ・ Covid-19
5 January 2021

Sweden country profile: Swedish Krona soars against the Dollar

The Swedish Krona has been in the news lately. Our research into the country will offer you an overview of why Sweden caught our attention at FlowBank and why there is more than just the Krona going for it.

Macro ・ Crypto ・ Technology ・ Covid-19 ・ Markets
24 December 2020

Investing perspective going into 2021

This year we experienced our first recession since the global meltdown of 2008, we radically changed our lifestyles, we confined, we lost our jobs, we saw dislocating ...

Covid-19 ・ Markets
16 November 2020

Vaccine trade: Buying indices of where the virus hit worse

A new trade is taking shape this week of buying indices like Spain’s IBEX and Italy’s FTSE MIB following vaccine news from Pfizer/BioNtech and now Moderna

Technology ・ Covid-19
12 October 2020

The race for COVID-19 vaccine, bet on the best horse

Two races are currently taking place in our backyard: rich countries are fighting to secure a large volume of vaccine for its population and pharmaceutical companies are sprinting to the phase 3 finish line to get their drug approved. The ...

Covid-19 ・ Markets
8 October 2020

Bitcoin pops on Square block buy, Dow highest in a month - DAY AHEAD

The price of Bitcoin got a boost from payment company Square buying $50 million in BTC, the Turkish lira dropped and the Dow Jones finished at its highest in a month.

Stocks ・ Covid-19
5 October 2020

Cineworld turns its projector off

Cineworld will operate major closing this week, putting on hold all of its movie theatres in the US and the UK, leaving over 45’000 workers unemployed.

Stocks ・ Technology ・ Covid-19
16 September 2020

AstraZeneca: the new potential healing druid

The pharma giant AstraZeneca is working on a new vaccine for Covid-19 and could be well on its way to success.

bg_newsletter

 

CFDs are complex instruments and are not suitable for everyone as they can rapidly trigger losses that exceed your deposits. You should consider whether you understand how CFDs work. Please see our Risk Disclosure Notice so you can fully understand the risks involved and whether you can afford to take the risk.


This website is owned and operated by FlowBank S.A, a company regulated by the Swiss Financial Market Supervisory Authority (FINMA) and a member of esisuisse. The list of banks and securities firms authorized by FINMA can be accessed here. Depositor protection in Switzerland is provided by esissuisse for a maximum of CHF 100,000.- per client. Details concerning this protection system are explained at www.esisuisse.ch/en

FlowBank is affiliated with the Swiss Banking Ombudsman. Therefore, if you wish to initiate a mediation procedure with the Swiss Banking Ombudsman after your complaint to FlowBank, please contact the Ombudsman according to the instructions provided on its website: https://bankingombudsman.ch/en/

 

The information on this site is not directed at residents of the United States, Belgium, Canada, or any person in any country or jurisdiction where such distribution or use would be contrary to local laws or regulations.

 

Trading Forex and other leveraged products carries high risks and may not be apt for everyone. Before you consider trading these instruments please assess your experience, goals, and financial situation. You could lose your initial investment, so don't use funds you can't afford to lose or that are essential for personal or family needs. You can consult a licensed financial advisor and ensure you have the risk tolerance and experience.


Apple, iPad, and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc.

FlowBank S.A, Esplanade de Pont-Rouge 9, 1211 Geneva 26, Switzerland
FlowBank S.A, Seidengasse 20, 8001 Zurich, Switzerland